Publikationen - Dr. rer. nat. Dirk Moser

2013

  • Ehlert T, Simon P, Moser DA. Epigenetics in sports.Sports Med. 2013 Feb;43(2):93-110.

2012

  • Neuberger EW, Moser DA, Jurkiewicz M, Simon P. Detection of EPO gene doping in blood. Drug Test Anal. 2012 Nov;4(11):859-69. 
  • Moser DA, Neuberger EW, Simon P.(submitted) A quick one-tube nested PCR-protocol for EPO transgene detection. Drug Test Anal. 2012 Nov;4(11):870-5.

2011

  • Neuberger EW, Moser DA, Simon P. Principle considerations for the use of transcriptomics in doping research. Drug Test Anal. 2011 Oct;3(10):668-75.
  • Mueller A, Armbruster D, Moser DA, Canli T, Lesch KP, Brocke B, Kirschbaum C. Interaction of Serotonin Transporter Gene-linked Polymorphic Region and Stressful Life Events on Stress Response. Neuropsychopharmacology 2011 Jun;36(7):1332-9.

2010

  • Philippidou D, Schmitt M, Moser DA, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S. Signatures of microRNAs and selected target genes in human melanoma. Cancer Research, 2010 May 15;70(10):4163-73
  • Pálmason H, Moser DA, Sigmund J, Vogler C, Hänig S, Schneider A, Seitz C, Marcus A, Meyer J, Freitag C. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. Journal of Neural Transmission, 2010 Feb 117(2):259-67
  • Brocke B, Lesch KP, Armbruster D, Moser DA, Müller A, Strobel A, Kirschbaum C. Stathmin, a gene regulating neural plasticity, affects fear and anxiety processing in humans. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics: 2010 Jan 5;153B(1):243-51

2009

  • Armbruster D*, Mueller A*, Moser DA, Lesch KP, Brocke B, Kirschbaum C. Interaction effect of D4 dopamine receptor gene and serotonin transporter promoter polymorphism on the cortisol stress response. Behavioural Neuroscience, 2009 Dec;123(6):1288-95
  • Kumsta R*, Moser DA*, Streit F, Koper JW, Meyer J, Wüst S. Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009 Jun 5;150B(4):476-82 *these authors contributed equally
  • Moser DA, Ekawardhani S, Kumsta R, Palmason H, Bock C, Athanassaidou Z, Lesch KP, Meyer J. Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional methylation site: Neuropsychopharmacology, 2009 Jan;34(2):458-467
  • Armbruster D, Moser DA, Hensch T, Strobel A, Kirschbaum C, Lesch KP, Brocke B. Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. International Journal of Neuropsychopharmacology, 2009 Apr;12(3):393-401

2002-2007

  • Moser DA, Molitor A, Kumsta R, Riederer P, Tatschner T, Meyer J. (2007) The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus. World Journal of Biological Psychiatry: 8(4):262-268
  • Buss C, Schuelter U, Hesse J, Moser DA, Phillips DI, Hellhammer D, Meyer J. (2007) Haploinsufficiency of the SERPINA6 gene is associated with severe muscle fatigue: A de novo mutation in corticosteroid-binding globulin deficiency. Journal of Neural Transmission: 114(5):563-569
  • Mossner R, Freitag CM, Marziniak M, Moser DA, Sommer C, Meyer J. (2006) The functional Val158Met variant of the COMT gene is not associated with migraine with or without aura. Journal of Headache and Pain: Jun; 7(3):165-166
  • Bellingrath S, Kumsta R, Meyer J, Moser DA, Federenko I, Hellhammer DH, Wüst S. (2005) Association of a polymorphism in the H6PD gene and basal cortisol secretion, body fat mass and leptin level. Zeitschrift fuer Medizinische Psychologie:111-117
  • Willmroth F, Spleiss O, Wiesmann K, Moser DA, Atmanspacher R, van Calker D. (2002) Expression of G-proteins and regulators of G-protein signalling in neutrophils of patients with bipolar disorder: effects of mood stabilizers. Bipolar Disorders: 4 Suppl 1:75-76